ACR Appropriateness Criteria Breast Cancer Screening

Journal of the American College of Radiology

Volumn 13, Issue 11, 2016, Pages R45-R49

  Mainiero, Martha B ^a   Lourenco, Ana ^a   Mahoney, Mary C ^b   Newell, Mary S ^c   Bailey, Lisa ^d,e   Barke, Lora D ^f   D'Orsi, Carl ^c   Harvey, Jennifer A ^g   Hayes, Mary K ^h   Huynh, Phan Tuong ⁱ   Jokich, Peter M ^j   Lee, Su Ju ^b   Lehman, Constance D ^k   Mankoff, David A ^k,l   Nepute, Joshua A ^m   Patel, Samir B ⁿ   Reynolds, Handel E ^o   Sutherland, M Linda ^p   Haffty, Bruce G ^q  

^a RHODE ISLAND HOSPITAL   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c EMORY UNIVERSITY HOSPITAL   (United States)

^d Imagimed LLC   (United States)

^e AMERICAN COLLEGE OF SURGEONS   (United States)

^f INVISION SALLY JOBE   (United States)

^g UNIVERSITY OF VIRGINIA MEDICAL CENTER   (United States)

^h MEMORIAL REGIONAL HOSPITAL   (United States)

ⁱ ST LUKE S EPISCOPAL HOSPITAL   (United States)

^j Rush Breast Imaging Center   (United States)

^k UNIVERSITY OF WASHINGTON   (United States)

^l Society of Nuclear Medicine   (United States)

^m UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

ⁿ Radiology Inc   (United States)

^o Radiology Association of Atlanta   (Georgia)

^p Newport Diagnostic Center   (United States)

^q ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

more..

Author keywords

Appropriateness criteria; breast cancer; breast MRI; breast ultrasound; mammography; screening

Indexed keywords

FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ARTICLE; BREAST CANCER; BREAST EXAMINATION; BREAST SPECIFIC GAMMA IMAGING; CANCER SCREENING; ECHOMAMMOGRAPHY; FAMILY HISTORY; FLUORESCENCE IMAGING; GENETIC PREDISPOSITION; HIGH RISK POPULATION; HUMAN; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION MAMMOGRAPHY; THERMOGRAPHY; BREAST TUMOR; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; EVIDENCE BASED MEDICINE; FEMALE; ONCOLOGY; PATHOLOGY; PRACTICE GUIDELINE; RADIOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARDS; UNITED STATES;

BREAST NEOPLASMS; EARLY DETECTION OF CANCER; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MEDICAL ONCOLOGY; PRACTICE GUIDELINES AS TOPIC; RADIOLOGY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, MAMMARY; UNITED STATES;

EID: 84995662267     PISSN: 15461440     EISSN: 1558349X     Source Type: Journal    
DOI: 10.1016/j.jacr.2016.09.021     Document Type: Article

References (29)

1. 1 Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev 15 (2006), 45–51.
2. 2 Duffy, S.W., Tabar, L., Chen, H.H., et al. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer 95 (2002), 458–469.
3. 3 Hendrick, R.E., Smith, R.A., Rutledge, J.H. III, Smart, C.R., Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr, 1997, 87–92.
4. 4 Tabar, L., Vitak, B., Chen, H.H., Yen, M.F., Duffy, S.W., Smith, R.A., Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 91 (2001), 1724–1731.
5. 5 Lee, C.H., Dershaw, D.D., Kopans, D., et al. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. JAm Coll Radiol 7 (2010), 18–27.
6. 6 Berg, W.A., Tailored supplemental screening for breast cancer: what now and what next?. Am J Roentgenol 192 (2009), 390–399.
7. 7 Brekelmans, C.T., Seynaeve, C., Bartels, C.C., et al. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol 19 (2001), 924–930.
8. 8 Chart, P.L., Franssen, E., Management of women at increased risk for breast cancer: preliminary results from a new program. CMAJ 157 (1997), 1235–1242.
9. 9 Macmillan, R.D., Screening women with a family history of breast cancer— results from the British Familial Breast Cancer Group. Eur J Surg Oncol 26 (2000), 149–152.
10. 10 Scheuer, L., Kauff, N., Robson, M., et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol 20 (2002), 1260–1268.
11. 11 Warner, E., Plewes, D.B., Shumak, R.S., et al. Comparison of breast magnetic resonance imaging,mammography,andultrasound for surveillance ofwomenat high risk for hereditary breast cancer. J Clin Oncol 19 (2001), 3524–3531.
12. 12 Hagen, A.I., Kvistad, K.A., Maehle, L., et al. Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series. Breast 16 (2007), 367–374.
13. 13 Hartman, A.R., Daniel, B.L., Kurian, A.W., et al. Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma. Cancer 100 (2004), 479–489.
14. 14 Kriege, M., Brekelmans, C.T., Boetes, C., et al. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition. Cancer 106 (2006), 2318–2326.
15. 15 Kuhl, C.K., Schrading, S., Leutner, C.C., et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23 (2005), 8469–8476.
16. 16 Leach, M.O., Boggis, C.R., Dixon, A.K., et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365 (2005), 1769–1778.
17. 17 Lehman, C.D., Isaacs, C., Schnall, M.D., et al. Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. Radiology 244 (2007), 381–388.
18. 18 Sardanelli, F., Podo, F., D'Agnolo, G., et al. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. Radiology 242 (2007), 698–715.
19. 19 Warner, E., Plewes, D.B., Hill, K.A., et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292 (2004), 1317–1325.
20. 20 Plevritis, S.K., Kurian, A.W., Sigal, B.M., et al. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA 295 (2006), 2374–2384.
21. 21 Taneja, C., Edelsberg, J., Weycker, D., Guo, A., Oster, G., Weinreb, J., Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women. J Am Coll Radiol 6 (2009), 171–179.
22. 22 Saslow, D., Boetes, C., Burke, W., et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57 (2007), 75–89.
23. 23 Brennan, S., Liberman, L., Dershaw, D.D., Morris, E., Breast MRI screening of women with a personal history of breast cancer. AJR Am J Roentgenol 195 (2010), 510–516.
24. 24 Sung, J.S., Malak, S.F., Bajaj, P., Alis, R., Dershaw, D.D., Morris, E.A., Screening breast MR imaging in women with a history of lobular carcinoma in situ. Radiology 261 (2011), 414–420.
25. 25 Berg, W.A., Blume, J.D., Cormack, J.B., et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 299 (2008), 2151–2163.
26. 26 Hendrick, R.E., Radiation doses and cancer risks from breast imaging studies. Radiology 257 (2010), 246–253.
27. 27 O'Connor, M.K., Li, H., Rhodes, D.J., Hruska, C.B., Clancy, C.B., Vetter, R.J., Comparison of radiation exposure and associated radiation-induced cancer risks from mammography and molecular imaging of the breast. Medical physics 37 (2010), 6187–6198.
28. 28 American College of Radiology. Manual on contrast media v7. Available at: http://www.acr.org/∼/media/ACR/Documents/PDF/QualitySafety/Resources/Contrast%20Manual/FullManual.pdf. Accessed November 14, 2012.
29. 29 American College of Radiology. ACR Appropriateness Criteria®: radiation dose assessment introduction. Available at: http://www.acr.org/∼/media/A27A29133302408BB86888EAFD460A1F.pdf. Accessed September 19, 2012.